Though ELISA tests (enzyme-linked immunosorbent assays) are the gold standard for diagnosing a whole slew of infectious diseases, the technology has remained stuck within hospital labs. What if you ...
Scientists say they have developed a new computational method to reduce variability in common research biomarker tests. They see their techniques as a promising step in improving the ability of ...
The launch follows increasing demand from the scientific community to study penKid - a biomarker reflecting the current state of kidney function in critical care environments. While SphingoTec's ...
LOGAN, Utah--(BUSINESS WIRE)--Quansys Biosciences, a leader in multiplex immunoassay technology, today announced the launch of the Q-View™ Imager Plus, a next-generation imaging device designed to ...
Testing for those who have developed antibodies against the coronavirus can help tackle the ongoing COVID-19 pandemic. Now, a new study has identified all the antibody tests available for the ...
The in-house ELISA SARS-CoV-2 serological assay, developed by the Armauer Hansen Research Institute (AHRI) in Ethiopia, measures anti-SARS-CoV-2 receptor binding domain (RBD) antibodies. This study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results